Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Infrared thermography: a scoping review of its possible role in the diagnosis and follow-up of leprosy neuropathy

Wim Brandsma J, Knulst-Verlaan C, Knulst AJ, et al. Lepra. Leprosy Review. 2025; 96 (3) : 1-10.
Download PDF
Publication

Demographic and clinical profile of leprosy patients in Lagos, Nigeria: a 17-year retrospective study

Cole-Adeife O, Dairo G, Agaga L, et al. Oxford University Press (OUP). Clinical and Experimental Dermatology. 2025;
Publication

Validation of the Hausa version of the EMIC-CSS and SDS among adults in Northern Nigeria

Dahiru T, Murphy-Okpala N, Abdullahi S, et al. Lepra. Leprosy Review. 2025; 96 (3) : 1-10.
Download PDF
Publication

Missed or misjudged? Revisiting Leprosy Through Six Cases: A Case Series of long-standing diagnostic dilemma in Patients of North India

Rawat P, Mishra R. European Journal of Cardiovascular Medicine. 2025;
Download PDF
Publication

Impact of protein prenylation inhibition on Mycobacterium leprae viability and IL-1ß production in infected macrophages

da Silva Rocha M, Rodrigues Pereira AM, Freire dos Santos PM, et al. American Society for Microbiology. Journal of Bacteriology. 2025; 207 (9) : 1-17.
Download PDF
Publication

Lepromatous leprosy: case report

Ramos-Aguila YDLC, Hernández-Ramos Y, Cuello-Carballo MB. AG Editor (Argentina). South Health and Policy. 2026;
Download PDF
Publication

Translation and cross-cultural validation of four tools for assessing stigma among community members and self-esteem among persons affected by leprosy in Nigeria

Murphy-Okpala N, Dahiru T, Ukwaja KN, et al. Lepra. Leprosy Review. 2025; 96 (3) : 1-9.
Download PDF
Publication

Lepromatous Lymphadenitis: A Rare Manifestation of LeprosyDiagnosed by Fine Needle Aspiration Cytology

Chitkara F, Pannu D, Saha D, et al. Annals of Pathology and Laboratory Medicine. 2025;
Download PDF
Publication

Coexistencia de infecciones micobacterianas en un paciente con fenómeno de Lucio. Reporte de caso

Gonzalez FJ, Moreira-Parra JA, Martinez-Mclanghilin NB, et al. Universidad del Pacifico - Paraguay. Revista científica ciencias de la salud. 2025;
Download PDF
Publication

Subpopulações de células B em lesões de hanseníase: desvendando a complexa interação

Froes Junior LAR, Pagliari C, Trindade MAB, et al. Elsevier BV. Anais Brasileiros de Dermatologia (Versão em Português). 2025; 100 (5) : 1-9.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD